Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 24, Núm. 2, pp. 227-235